Last reviewed · How we verify
NCT03212066: MasterMind
Master Mind Program Evaluation Study
NA trial testing Master Mind in Substance Abuse in 518 participants. Completed in 30 August 2019.
30 August 2019
Quick facts
| Lead sponsor | Innovation Research & Training |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 518 |
| Start date | 23 August 2017 |
| Primary completion | 30 August 2019 |
| Estimated completion | 30 August 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Master Mind
Conditions studied
- Substance Abuse — all drugs for Substance Abuse →
- Mindfulness — all drugs for Mindfulness →
Sponsor
Innovation Research & Training
Who can join
Adults 8 to 12, any sex, with Substance Abuse or Mindfulness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to conduct a randomized controlled trial to evaluate the efficacy of the Master Mind program, a mindfulness education substance abuse prevention program. The program has the goal of enhancing coping strategies and decision-making skills and preventing substance abuse in late elementary school students.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03212066
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Substance Abuse
Currently open trials in the same condition.
- NCT06627764 — SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Immigrant Families · NA · recruiting
- NCT06899308 — Health Surveillance at Constructor University Bremen (CUB) and Among HAW-Hamburg Employees · recruiting
- NCT06880705 — The Trans-Led Care Study · NA · recruiting
- NCT06852170 — Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prev · NA · recruiting
- NCT05776316 — Harm Reduction Services · NA · recruiting
Other Innovation Research & Training trials
Trials by the same sponsor.
- NCT07233967 — Parent Resource About Pediatric Clinical Trials · NA · completed
- NCT06408818 — Study of an Online Program to Help Parents Talk With Their Tween Children About Health, Gender, Body-Image, and Relation · NA · completed
- NCT05849441 — Mindfulness Program for Adolescents With 22q11DS · NA · completed
- NCT05714943 — Website for Adolescents About Pediatric Clinical Trials · NA · completed
- NCT05900115 — Feasibility Study of a Web-based Program to Help Parents of Middle School Students Effectively Communicate With Their Ch · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03212066 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Innovation Research & Training
- Last refreshed: 10 December 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03212066.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing